Conexxence Injection
Product Images NDC 65219-668
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Conexxence (NDC 65219-668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Tra1a 0001 02)
Figure B (Tra1a 0001 03)
Figure C (Tra1a 0001 04)
Figure D (Tra1a 0001 05)
Figure (Tra1a 0001 06)
Figure (Tra1a 0001 07)
Principal Display Panel – 60 mg/ml Carton Label (Tra1a 0001 08)
Principal Display Panel – 60 mg/ml Syringe Label (Tra1a 0001 09)
This text appears to be a label for a medication called Conexxence denosumab-bnht. It is an injection intended for subcutaneous use only. The manufacturer is Fresenius Kabi USA, LLC. The National Drug Code (NDC) is 65219-668-01 and it is available by prescription only. Additionally, there are lot and expiration date fields provided on the label.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.